Discrimination between Metastases and Glioblastomas multiforme based on morphometrical analysis of MR images by Blanchet, L.M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/84443
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
ORIGINAL
RESEARCH
Discrimination between Metastasis and
Glioblastoma Multiforme Based on
Morphometric Analysis of MR Images
L. Blanchet
P.W.T. Krooshof
G.J. Postma
A.J. Idema
B. Goraj
A. Heerschap
L.M.C. Buydens
BACKGROUND AND PURPOSE: Solitary MET and GBM are difficult to distinguish by using MR imaging.
Differentiation is useful before any metastatic work-up or biopsy. Our hypothesis was that MET and
GBM tumors differ in morphology. Shape analysis was proposed as an indicator for discriminating
these 2 types of brain pathologies. The purpose of this study was to evaluate the accuracy of this
approach in the discrimination of GBMs and brain METs.
MATERIALS AND METHODS: The dataset consisted of 33 brain MR imaging sets of untreated patients,
of which 18 patients were diagnosed as having a GBM and 15 patients, as having solitary metastatic
brain tumor. The MR imaging was segmented by using the K-means algorithm. The resulting set of
classes (also called “clusters”) represented the variety of tissues observed. A morphology-based
approach allowed discrimination of the 2 types of tumors. This approach was validated by a leave-1-
patient-out procedure.
RESULTS: A method was developed for the discrimination of GBMs and solitary METs. Two masses
out of 33 were wrongly classified; the overall results were accurate in 93.9% of the observed cases.
CONCLUSIONS: A semiautomated method based on a morphologic analysis was developed. Its
application was found to be useful in the discrimination of GBM from solitary MET.
ABBREVIATIONS: CNS  central nervous system; GBM  glioblastoma multiforme; MET 
metastasis; MRSI  MR spectroscopic imaging
Gliomas are themost common andpotentiallymost aggres-sive type of primary brain tumors in adults. GBM is the
most malignant form of glioma. Its specific growth pattern is
characterized by an extensive and diffuse infiltration of tumor
cells in the neuropil (ie, the attenuated network of interwoven
neuronal and glial cell processes). This aspect is a major factor
in therapeutic surgical failure.1 The growth of brainmetastases
is a complexmultistage process,mediated bymolecularmech-
anisms. The cancer cells must transform, grow, and be trans-
ported to theCNS,where they can lie dormant before invading
and growing further.2 The clinical symptoms associated with
GBM are similar to those of brainMET. However, each tumor
type has a different biologic nature and, therefore, requires
different treatment strategies.3,4 In most cases, a definitive di-
agnosis is based on the histopathologic analysis of a biopsy
sample. However, for some cases, the differentiation of MET
and GBM can be made with conventional MR imaging. For
example, a solitary mass spanning the corpus callosum and
both frontal lobes cannot be an MET. In other cases, it is not
possible to differentiate these 2 types of tumors because the
radiologic visualization of the invasive front of diffuse glio-
blastomas is too difficult. Generally, GBM is a solitary tumor
and MET is not, but there are exceptions to this rule. In such
cases, it is difficult to distinguish GBM and MET on the basis
of MR imaging. The use of noninvasive methods is preferable
or sometimes mandatory when a biopsy is impossible. This is
the case when the mass is located near an eloquent area or
when the patient’s advanced agemakes the procedure too dan-
gerous. A better differentiation of the 2 types of tumor by
noninvasive methods would, therefore, be beneficial.
The aggressive proliferation and invasiveness of GBM can
influence the tumormorphology. Indeed, recent studies5 have
shown that clusters of cells may separate from the tumor sur-
face when the proliferation is high (ie, for GBM). Moreover,
the tumor growth is known to be dependent on fluctuations in
oxygen and nutrient supply.6 As a consequence, some growth
directions would be favored (at a macroscopic scale) and in-
fluence the tumor morphology. Furthermore, GBMs are ex-
pected to follow a growth pattern via white matter tracts, the
CSF, or meninges.4 Therefore, the global shape of a GBM tu-
mor is expected to be quite complex.6 In contrast, METs ex-
pandmore homogeneously and are anticipated to bemorpho-
logically similar to a sphere.7 Our hypothesis was that the
morphology of the tumor could be used to efficiently differ-
entiate solitary MET and GBM.
Various approaches have been proposed in the past years to
improve the differential diagnosis of GBM andMET based on
MR imaging.8Most require the acquisition of data in addition
to conventional MR imaging by using different techniques
such as diffusion imaging,9,10 perfusion imaging,11 or
MRSI,11-13 followed by various statistical analyses.14-19 These
different works will be discussed later, but in brief, the level of
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inhomogeneity of a tumor was expected to be related to its
nature. High-accuracy values were obtained in the distinction
of glioma versusmeningioma and of primary tumors (all types
taken together) versus secondary tumors. However, the dis-
tinction of GBM and MET appears to be difficult, with re-
ported correct classifications below 60%.15,18
In this work, we focused on a semiautomated method per-
mitting the localization and definition of the region of interest
within volumetric MR imaging data. The resulting segmenta-
tion allowed defining a tumor shape that is classified as MET
or GBM according to a geometric descriptor. The objective
was to accurately differentiate solitaryMETandGBMbyusing
a semiautomatedmethod for the analysis ofMR imaging data.
Materials and Methods
Patients
In agreement with the local ethics committee, 33 patients with his-
topathologically proved GBM (18 patients) or solitary MET (15 pa-
tients) signed an informed consent to be included in the studies, part
of the European Project eTUMOR. The analysis proposed here is
retrospective. The patients were not subjected to any treatments be-
fore the radiologic examinations and had no prior history of surgery,
chemotherapy, or radiation therapy to the intracranial structures.
The group of patients included 24 men and 9 women with an age at
the time of radiologic examinations in the range of 29–78 years
(mean, 54.4 12.5 years). This cohort consisted of regular patients of
the Radboud Medical Center who were in observation between
March 2006 and January 2008. Each patient’s tumor type was deter-
mined bymeans of central consensus histopathologic validation after
biopsy or after a surgical specimen had been obtained on the basis of
the neuronavigation MR imaging scan.
Data Acquisition
The MR imaging data of each patient were acquired on a 3T whole-
body system (MagnetomTrio; Siemens, Erlangen, Germany), follow-
ing a standard protocol. The body coil was used for excitation, and a
12-channel receive-only head coil was used for reception of the MR
imaging signal intensity. The MR imaging protocol included T2-
weighted axial images and T1-weighted images with andwithout gad-
olinium contrast enhancement. In some cases, T1-weighted images
without gadoliniumwere not acquired. Depending on the patient, 26
or 159 T2-weighted turbo spin-echo images (TR  4040 ms, TE 
102 ms) were obtained with a resolution of 0.6  0.6 mm and a
section thickness of 5 mm (leading to 26 images) or 1 mm (providing
159 T2 images). The intersection gap was set to 10% of section thick-
ness. For T1-weighted images a 3D rapid gradient-echo sequence was
used (resolution, 1  1  1 mm; TR, 2300 ms; TI, 1100 ms; TE, 4.7
ms). T1-weighted images with contrast enhancement were obtained
with the same sequence after injection of 15 mL of 0.5 mol/L gadot-
erate meglumine (Dotarem; Guerbet, Aulnay-sous-Bois, France).
The patients whose tumor could only be visualized in fewer than 5
consecutive sections were excluded from the study.
Data Analysis
The images were aligned and resampled by using Slicer, Version 2.6
(www.slicer.org) to fit to the resolution of T2-weighted images. The
next part of the data analysis, toward image segmentation, is summa-
rized in Fig 1. The aligned images weremerged in amultidimensional
array. The first 3 dimensions corresponded to the 3 spatial coordi-
nates and the fourth, to the type of image (T1-weighted, T2-weighted,
or gadolinium-enhanced T1). The analysis then was focused on a
given section in the axial plane of the brainwhere the tumor lesion can
be seen. The skull was removed from the image by using an in-house
written program. In the following sections, we first define the variable
space in which the data will be segmented. Subsequently, the proce-
dure for selecting the region of interest is discussed in detail. Finally,
in the last section the K-means algorithm used for segmentation and
the morphologic analysis are presented. All the analyses described
here were performed blinded to the histologic diagnosis.
Variables Space
Each voxel was considered as an independent sample. The intensities
measured with precontrast T1, T2, and gadolinium-enhanced T1MR
imagingwere the 3 variables that defined each voxel. TheMR imaging
data could be projected in a variables space in which each voxel was
represented by a point at the coordinates corresponding to the inten-
sities of each variable. Only 3 variables were used; it was then possible
to represent this new space. Figure 2 gives an example of such variable
space in which 100 samples are visible and regrouped in 3 classes
identified as 3 clouds of points. This simulated example shows how
the projection in the variable space allows regrouping the samples in
different groups or “classes.”
Selection of the Region of Interest
The tumor was visually located by the human operator in each 2D
axial plane. A region corresponding to apparently normal tissues was
selected as a reference. This reference is situated in the contraparietal
region, if possible at a position similar to that of the tumor. The
reference region should only contain tissues expected to be normal. If
the tumor was close to the interhemispheric fissure, the reference was
chosen in a more distant region of the brain. The different values of
voxels in the reference regionwere averaged to obtain single reference
intensities for the 3 variables (T1, T2, and gadolinium-enhanced T1),
which can be projected in the variable space as a single point. This
point was then used to determinewhich voxels differed themost from
normal tissue. This was done by calculating the Euclidian distance di
of each voxel i to the reference r (in the variable space) as follows:
d1  
j  1
3
 xi, j  xr, j
2,
where xi,j is the value of variable j of voxel i and xr,j is the value of the
same variable for the reference. By plotting these distances in the
original MR imaging plane, we obtained a distance map. This map
clearly showed a region with higher intensity corresponding to the
voxels that differ most from the reference (ie, the tissues the most
different fromnormal tissues). The region of interest (ie, the complete
area affected by the tumor) could now be selected. We chose to in-
clude the entire suspected region, including additional healthy tissues
in the surroundings. This selection step ensured that the entire lesion
was selected and that no secondary lesion was left out. The region of
interest was then segmented by using a K-means algorithm.
Segmentation Using K-Means Algorithm
The segmentation of the region of interest in tumorous and nontu-
morous regions requires assigning the corresponding voxels to a
given number of groups. Many algorithms are available for such a
task.20 We chose to focus on the partitional method named
K-means.21 This method is computationally efficient and can be ap-
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plied to datasets including a high number of samples such as the MR
imaging data used here.
The number of expected classes was defined beforehand. The dis-
tance (in the variable space) between each voxel and each class center
(also called centroid) was computed, and every voxel was assigned to
the classwith the closest center.However, the position of a class center
cannot be known in advance. The algorithm can be decomposed in
the following points:
1) Select random “class centers.”
2) Calculate the distances between the centers and the voxels.
3) Assign all the voxels to the different classes.
4) Calculate the new class centers.
5) Return to step 2 until the convergence is achieved (the voxel
assignment is the same as that in the previous iteration).
The class assignment was then color-coded, and the region of
interest was depicted as presented in Fig 1.
For each image, this procedure was repeated by using different
numbers of classes to optimize the description of the tumor. In gen-
eral, 3–6 classes permitted the efficient distinction of healthy tissues,
CSF (if present in the region of interest), edema, and tumor tissues.
One type of tissue was not necessarily represented by only 1 class. A
filtering algorithm was then applied to eliminate all spatial areas
formed by only 1 voxel. These voxels were reattributed to other classes
in accordance with the neighboring voxels. The resulting classes rep-
resenting normal tissues (similar to the reference chosen) were dis-
carded. In Fig 1, they are represented by green and yellow classes.
Then the operator selected the classes corresponding to the tumor
core. It is possible that the classes that outline the tumor corewere also
present outside the tumor core. In such a case, the 2 types of tissues
(tumor core and not tumor core) were spatially easily distinguishable.
Selecting 1 voxel from each area within the tumor core allows assign-
ing all the voxels of these areas as tumor core. A binary image of the
tumor was created subsequently.
Morphologic Analysis
Once the tumor shape has been defined, it is necessary to discriminate
between MET and GBM. The shape of the tumor was evaluated by
using a basic criterion. The largest dimension of the binary map
was evaluated. This dimension was used to construct a square in
which the binary tumor image fits. The ratio of white voxels in the
binary map (evaluated as tumor) against the total number of pixels
in that square was calculated. When the tumor core is spherical (or
close to it), the binary image obtained should be a circle covering
78.5% of the square. This value comes from the area of a circle with
a radius r (ie, .r2) divided by the area of the corresponding square
(ie, [2.r]2), so it is exactly /4. Conversely when the tumor is
Fig 1. Scheme followed to select the region of interest containing the tumor and the corresponding segmented image. The area of the tumor relative to the tangent square is equal to
0.68.
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nonspheric, the described shape does not fit the square so well,
leading to a lower ratio. In most cases, the tumor lesion was visible
in multiple axial sections of the volumetric MR imaging data. The
ratio was calculated for each section. Means and SDs of the ratios
were calculated for each patient. The mean was used as the global
result for the patient.
The number of MR imaging sections analyzed per patient var-
ied between 1 and 20 because of the size of the tumor and the
spatial resolution used. The images corresponding to the lowest
and highest position of the tumor lesion were discarded. In these
sections, the tumor lesion is, in general, small and would probably
appear circular.
The validationmethod used for the determination of the discrim-
inating value, between GBM and MET, was leave-1-patient-out.20
The principle was to exclude 1 patient from the dataset and then
establish the discriminating value on the remaining data. The diagno-
sis of the patient left out was then predicted on the basis of the ob-
tained discriminating value. This procedure was repeated for each
patient, and the number of correct predictions was evaluated. In this
work, 33 models can be constructed, each excluding 1 patient.
All the calculations concerning the data analysis were performed
by using Matlab, Version 7.6 (MathWorks, Natick, Massachusetts).
Results
The strategy proposed here and detailed in the “Materials and
Methods” section aims to distinguish GBM and MET on the
basis of a simple shape descriptor. Because 3D data were avail-
able, the circularity of the tumor was evaluated in the different
axial sections of the MR imaging volumes. The use of the K-
means algorithm was helpful to divide the region of interest,
by using the different MR images, into shapes from which the
tumor core can be outlined. On-line Table 1 presents the re-
sults obtained for the 33 cases. The age, sex, histopathologic
diagnosis, and type of biopsy undergone for each patient are
also provided. On the basis of our method, 31 of 33 diagnoses
are in correspondencewith the histopathologic diagnoses. The
2 misclassified cases (cases 1 and 16) are noted. These 2 cases
will be discussed later.
Metastasis Example
As an example of our approach, we describe a patient with
MET (Fig 1). The tumor core is mainly described by 5 classes.
Two classes (brown and orange) appeared to be limited to the
gadolinium-enhanced region only (forming a border). Three
classes were present within this border (probably necrosis), as
well as outside, but the different areas belonging to the same
class (within and outside of the tumor core) were spatially
separated. Using our method, the border and the area inside
this border were assigned to the tumor core. The other areas
(ie, outside the tumor core) were then automatically assigned
to a second class (not tumor core). The results are presented in
a binarymap (Fig 1, bottom right). The shape descriptor value
in this section was equal to 0.68.
GBM Example
The same procedure was applied to analyze the GBM tu-
mors. Figure 3 summarizes the main steps of the method
and presents the results obtained for a representative exam-
ple of GBM. The region-of-interest segmentation easily
permitted isolating the tumor in brown (corresponding to
the gadolinium-enhanced part of the tissues) and partly in
orange and dark blue. The 2 latter classes were, however,
also seen in the surrounding region. It was then necessary to
select the tumoral regions. The other classes represent the
Fig 2. 3D simulated variable space in which each point represents a voxel. Three classes of points (circle, cross, and triangle) are visible and are clearly separated from each other in
this space.
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healthy tissues (light blue and yellow). One can observe that
the tumor shape differs from a circle, in accordance with
our hypothesis. This tumor was described by our shape
descriptor by a value of 0.40.
Global Classification and Setting of the Discriminating
Value
Our approach was applied to 33 patients. Each tumor was
represented by several MR imaging sections. The shape de-
scriptor values were then used to determine the type of tumor,
as can be seen in Fig 4. Each patient is represented by a vertical
line, the 3 points represent the mean (center point) and the
mean  SD, the triangles correspond to patients with GBM,
and the circles, to patients with MET. The 2 types of tumors
form 2 distinct groups in this figure. The leave-1-patient-out
cross-validation was used to set the optimal discriminating
value at 0.53. Depending on which patient was excluded, the
value varied between 0.51 and 0.54. The discriminating value
led to the correct diagnostic prediction in 31 of 33 cases
(93.9%).
Two tumors were misclassified, 1 MET and 1 GBM. They
are both represented in Fig 5. The final diagnosis for 1 of these
cases was a tumor originating from an inverted papilloma. It
should, therefore, have been classified as MET and not as
GBM. The growth of such a tumor is known to be inhomoge-
neous. Therefore, the tumor was not similar to a circle and did
not fulfill our primary hypothesis about the shape of MET.
This case would have been identified by classic inspection of
the data. The secondmisclassificationwas a GBMpresenting a
shape very similar to that of a sphere, which induced the clas-
sification error.
Fig 4. Mean and SD of the shape descriptors obtained on 33 patients affected by an MET
(circles) or a GBM (triangles) tumor. The score obtained corresponds to the relative area of
the tumor to the tangent square.
Fig 3. Binary representation of a GBM obtained after merging the relevant classes obtained through K-means. The relative surface of the tumor compared with the tangent square is equal to 0.40.
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Discussion
As stated before, GBM and MET have different biologic na-
tures and require different treatment strategies.3,4 However,
both types of tumors share the same clinical symptoms.More-
over, solitary MET and GBM are difficult to distinguish by
using MR imaging. In most cases, a definitive diagnosis is
based on a histopathologic analysis of a biopsy sample. It is,
however, useful to perform this discrimination before any
metastatic work-up or biopsy. The analysis of MRSI has been
proved efficient to classify various types of brain tumors but
not to differentiate a solitary MET from GBM.16 For the
MET-versus-GBM discrimination, the MRSI analysis pro-
posed by Devos et al15 led to a correct result in only 59% of the
126 studied spectra. A multicenter study showed that the dis-
crimination of GBM versus MET is the most difficult one.16
Moreover, MRSI is not a readily available tool in most radiol-
ogy departments and requires more examination time and
expertise for proper signal-intensity processing and spectra
interpretation. For that reason, pattern-recognition systems
based on routinely acquired MR images have also been
investigated.
Textural analysis has been proposed17 jointly with neural
networks18 or support vector machines19 for classifying brain
tumors. However, Georgiadis et al18 obtained a percentage of
correct classification equal to 56% (on 48 cases) on the GBM/
MET problem. The use of perfusion and diffusion MR imag-
ing provided encouraging results based on the calculation of
the relative cerebral blood volume,8,22,23 but no accuracy val-
ues were provided on the discrimination of GBM from MET.
Therefore, the purpose of our work was to propose a semiau-
tomated method facilitating the differentiation of GBM from
solitary metastases based on standard MR imaging data only.
The method proposed here uses a semiautomated segmenta-
tion of the MR imaging data and a shape description of the
tumor. It correctly diagnosed 31 of 33 patients (ie, 93.9%). The
invasive growth pattern of GBM seems to influence the tumor
shape enough to permit a classification on the basis of a shape
descriptor.
Values Obtained in Practice
In the first example presented in the “Results” section, the
value for the descriptor is 0.68. This is lower than the theoretic
value of 0.78 expected for a perfectly spheric lesion. This ob-
servation is true for all the metastases cases. Two reasons may
explain this deviation from the ideal case. First, the tumor
description is not perfect. Some voxels are missing inside the
tumor. These have been attributed to a class not used to de-
scribe the tumor core. These voxels belong to the same class as
normal tissue, but this association does not necessarily mean
that the voxels are healthy. Second, the tumor is not a perfect
sphere but corresponds more to an ellipsoid. These 2 aspects
will be addressed in futureworks, but they did not significantly
affect the obtained results.
Limitations
The main limitation of this approach is its dependence on a
human analysis of the K-means results. Indeed, an operator
must select the classes representing the tumor core.
The images used during the analysis must contain com-
plete cross-sections of the tumor. However, it is preferable to
avoid considering the first and last section of the tumor vol-
ume. These 2 positions will certainly be described as circular,
even if the tumor as a whole is not spheric. The size of the
tumor must also be considered. The shape of a small tumor is
probably still independent of the growth pattern (ie, still
spheric).
The analysis proposed here relies on the segmentation of
2D axial images. The size of the tumor lesion and the resolu-
tion used during the measurement clearly influence the num-
ber of usable sections per patient.Obviously, a large number of
sections gives more confidence on the diagnosis, but individ-
ual sections seem to give an acceptable estimation of the over-
all score. Indeed, the SD of the scores of the different sections
from the different patients is relatively small. Even though for
several patients 26 images were available, and for other pa-
tients 159 images, the segmentation process is performed on 1
section at the time. The number of sections is, therefore, not
Fig 5. Gadolinium-enhanced T1 images of an MET (A) and a GBM (B), which were misassigned by this method. The MET is noncircular; this tumor started extracranialy (at the level of
the ear) and grew intracranialy. The GBM appears to be circular and is, therefore, predicted as an MET.
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an issue. However, it would become a problem if the segmen-
tation had been calculated on the complete volume at once.
The resolution along the vertical axis would then vary and
make the comparison between patients difficult.
AlthoughMET and GBM are the most common tumors in
the human brain, in clinical practice other brain tumor types
should be considered. This method has not yet been tested
with such a diverse range of tumor types. In such cases, the use
of MRSI is an interesting solution because it allows distin-
guishingmost of the tumor types fromGBMandMET. There-
fore, ifMRSI permits concluding that the tumor is notGBMor
MET, it is not necessary to apply the shape-description
method proposed here.16
Thirty-three selected patients cannot be considered statis-
tically representative of the total population affected by these 2
types of brain tumors. We plan to expand this study to new
patients in the future, but the work presented here provides a
proof of principle for the current method.
Future works on this specific problem will focus on the
extension of this method to 3Dmeasurements and to spectral
imaging. Indeed, the method proposed here uses 1 axial plane
at a time. Using the complete volume at once would probably
enhance the description of the tumor shape. A study of differ-
ent shape descriptors is also envisioned to detect multiple
types of shapes.
Finally, this method offers an interesting complement to
the classic MR imaging features. Indeed the faulty case linked
to an inverting papilloma presented in Fig 5 would have obvi-
ously been detected as an abnormal case by an expert. On the
other hand, the method presented here allows discriminating
cases in which the usual MR imaging examination does not
provide a clear answer. The segmentation of the image and
shape description of the tumor are, therefore, proposed as
support for a decision, but not as a replacement of the expert
analysis.
Conclusions
The presented method is proposed as support for clinical di-
agnosis and as a first step toward a new way to differentiate
brain tumors. It was found to efficiently classify solitary MET
and GBM in 31 of 33 patients (93.9% of the cases). The
method is proposed as a decision support tool and is not in-
tended to replace expert assessment in diagnosis.
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